Literature DB >> 32376299

Effect of Chlorella vulgaris enriched diet on growth performance, hemato-immunological responses, antioxidant and transcriptomics profile disorders caused by deltamethrin toxicity in Nile tilapia (Oreochromis niloticus).

Essam A Mahmoud1, Badawi M El-Sayed2, Yasser H Mahsoub3, Abd Elhakeem I El-Murr3, Ahmed N F Neamat-Allah1.   

Abstract

The toxic effect of deltamethrin (DM) was documented in aquaculture. There is no obtainable data on the effect of Chlorella vulgaris against DM toxicity. The current study focused on the effect of dietary supplementation with C. vulgaris (CV) on growth performance, innate immune response, antioxidant activities, and transcriptomics disorders induced by sub-lethal dose of DM in Oreochromis niloticus. A total number of 216 O. niloticus divided into four groups with tri-replicates. The 1st control group (CT) fed a basal diet, the second group fed diet enriched with 5% CV. The third group was exposed to DM (15 μg/L), where the last group fed CV and simultaneously exposed to DM as previous-mentioned. The procedure of CV feeding and DM exposure were continued for two months. Exposures to DM revealed in stunting of the growth parameters and lessening of survival ratio of tilapias with a significant decline of the erythrogram (macrocytic hypochromic anemic picture), and leucocytes immune cells and related parameters (immunoglobulin M, lysozyme) and sever shifting in the antioxidant indicators. Sever raise was monitored in hepatic and kidney markers. Also, genes expression related to immune and antioxidant parameters were severely impacted. Where tilapias received CV showed a significant increase in the growth and immune parameters besides to an improvement of hematological, antioxidant values and their related genes expressions. The fourth group that received CV simultaneous with DM exposure showed a soothing of the previous indicators and markers toward the values of tilapias fed on basal diet (CT). In turn, CV supplementation may be presented a protective effect alongside DM toxicity in O. niloticus appeared through soothing of the immune, antioxidant and related genes expressions in addition to its hepato-renal protective effects. Therefore, the current study recommended that an incorporating of 5% CV for tilapias diet could improve their growth performance, immunity, antioxidant and transcriptomics disorders induced by deltamethrin.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antioxidant; Chlorella; Growth; Health status; Hematology; Immunity; Oreochromis niloticus

Mesh:

Substances:

Year:  2020        PMID: 32376299     DOI: 10.1016/j.fsi.2020.04.061

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  4 in total

1.  Effect of the Lipid Fraction of Microalgae on Biochemical Parameters in Female C57BL/6 Mice.

Authors:  A P Lykov; I P Uvarov; R G Gevorgiz; S N Zheleznova
Journal:  Bull Exp Biol Med       Date:  2022-01-10       Impact factor: 0.804

2.  Immunosuppressive Effects of Thallium Toxicity in Nile Tilapia Fingerlings: Elucidating the Rescue Role of Astragalus membranaceus Polysaccharides.

Authors:  Mayada R Farag; Mahmoud Alagawany; Samah R Khalil; Eman W El-Hady; Walaa M Elhady; Tamer Ahmed Ismail; Carlotta Marini; Alessandro Di Cerbo; Hany M R Abdel-Latif
Journal:  Front Vet Sci       Date:  2022-06-09

3.  New insight on some selected nanoparticles as an effective adsorbent toward diminishing the health risk of deltamethrin contaminated water.

Authors:  Samar M Ibrahium; Ahmed A Farghali; Rehab Mahmoud; Ahmed A Wahba; Saeed El-Ashram; Hesham A Mahran; Shawky M Aboelhadid
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

4.  Improving growth properties and phytochemical compounds of Echinacea purpurea (L.) medicinal plant using novel nitrogen slow release fertilizer under greenhouse conditions.

Authors:  Fatemeh Ahmadi; Abbas Samadi; Amir Rahimi
Journal:  Sci Rep       Date:  2020-08-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.